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ABSTRACT Cyclic di-AMP is a recently identiﬁed second messenger exploited by
a number of Gram-positive bacteria to regulate important biological processes.
Here, we studied the phenotypic alterations induced by the increased intracellu-
lar c-di-AMP levels in Streptococcus gallolyticus, an opportunistic pathogen re-
sponsible for septicemia and endocarditis in the elderly. We report that an S.
gallolyticus c-di-AMP phosphodiesterase gdpP knockout mutant, which displays a
1.5-fold higher intracellular c-di-AMP levels than the parental strain UCN34, is
more sensitive to osmotic stress and is morphologically smaller than the parental
strain. Unexpectedly, we found that a higher level of c-di-AMP reduced bioﬁlm
formation of S. gallolyticus on abiotic surfaces and reduced adherence and cell
aggregation on human intestinal cells. A genome-wide transcriptomic analysis in-
dicated that c-di-AMP regulates many biological processes in S. gallolyticus, in-
cluding the expression of various ABC transporters and disease-associated genes
encoding bacteriocin and Pil3 pilus. Complementation of the gdpP in-frame dele-
tion mutant with a plasmid carrying gdpP in trans from its native promoter re-
stored bacterial morphology, tolerance to osmotic stress, bioﬁlm formation, ad-
herence to intestinal cells, bacteriocin production, and Pil3 pilus expression. Our
results indicate that c-di-AMP is a pleiotropic signaling molecule in S. gallolyticus
that may be important for S. gallolyticus pathogenesis.
IMPORTANCE Streptococcus gallolyticus is an opportunistic pathogen responsible for
septicemia and endocarditis in the elderly and is also strongly associated with colo-
rectal cancer. S. gallolyticus can form bioﬁlms, express speciﬁc pili to colonize the
host tissues, and produce a speciﬁc bacteriocin allowing killing of commensal bacte-
ria in the murine colon. Nevertheless, how the expression of these colonization fac-
tors is regulated remains largely unknown. Here, we show that c-di-AMP plays pleio-
tropic roles in S. gallolyticus, controlling the tolerance to osmotic stress, cell size,
bioﬁlm formation on abiotic surfaces, adherence and cell aggregation on human in-
testinal cells, expression of Pil3 pilus, and production of bacteriocin. This study indi-
cates that c-di-AMP may constitute a key regulatory molecule for S. gallolyticus host
colonization and pathogenesis.
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Streptococcus gallolyticus subsp. gallolyticus was previously known as Streptococcusbovis biotype I. This Gram-positive bacterium belonging to the group D Streptococ-
cus is an emerging pathogen responsible for septicemia and infective endocarditis (IE)
in the elderly. S. gallolyticus infections represent up to 25% of all cases of IE (1) and up
to 94.5% of IE caused by group D Streptococcus (2). Once established, IE is usually
difﬁcult to treat and has an in-hospital mortality of up to 22% (3–5), and high-risk
surgery interventions are often needed to resolve the infection (4–6). Importantly, S.
gallolyticus also has a strong association with the occurrence of colorectal cancer in
endocarditis patients (7, 8). Two recent studies indicated that S. gallolyticus is both a
driver and a passenger in colonic tumorigenesis. On one hand, S. gallolyticus subsp.
gallolyticus can accelerate colorectal cancer development by inducing cell proliferation
through the -catenin pathway (9); on the other hand, S. gallolyticus can take advan-
tage of tumoral conditions to outcompete the colonic microbiota members, such as
Enterococcus faecalis, through the production of a speciﬁc bacteriocin named gallocin
(10). S. gallolyticus was also shown to express two speciﬁc pili named Pil1 and Pil3,
which are involved in collagen and mucin binding, respectively. These two speciﬁc pili
allow S. gallolyticus to attach at infection sites (i.e., cardiac valves and colon, respec-
tively) and play a role in bioﬁlm formation (11, 12). While these studies provided
important clues to understand S. gallolyticus pathogenicity, not much is known about
the signal(s) governing the induction of virulence.
In bacteria, second messenger signaling molecules are exploited to regulate impor-
tant physiological functions, including bioﬁlm formation and virulence. Among these
molecules, cyclic di-AMP (c-di-AMP) has gained attention due to its widespread pres-
ence in Gram-positive bacteria, its essentiality for survival in certain conditions, and its
pleiotropic role as both an intracellular and extracellular molecule modulating many
biological processes, including the host immune responses (13–16).
c-di-AMP is synthesized by DisA_N or DAC domain-containing diadenylate cyclases
(DACs) and hydrolyzed by DHH/DHHA1 or HD-domain-containing phosphodiesterases
(PDEs) (17–21). Unlike Bacillus and Clostridium spp., which carry multiple DACs in their
genomes, Firmicutes, such as Streptococcus and Staphylococcus spp., are known to carry
only one DAC (commonly encoded by dacA) (15, 18, 22). Previous attempts to delete
dacA from Listeria monocytogenes and Streptococcus pyogenes and all DACs from
Bacillus subtilis using conventional gene deletion protocols were unsuccessful (13,
22–24), suggesting that c-di-AMP is essential for bacterial growth in standard laboratory
culturing conditions. It is now known that c-di-AMP is dispensable for growth in
specially formulated media and under anaerobic culturing conditions (25–28). However,
the deletion of dacA often results in the occurrence of compensatory mutations (27, 28).
Therefore, c-di-AMP PDE deletion mutants were particularly useful to address the
regulatory roles of c-di-AMP in Gram-positive bacteria (29–31).
Here, we constructed and characterized a c-di-AMP PDE, gdpP deletion mutant
in S. gallolyticus subsp. gallolyticus UCN34. We found that the S. gallolyticus subsp.
gallolyticus UCN34 ΔgdpP mutant was morphologically smaller than the parental
strain UCN34, more sensitive to osmotic stress, formed less bioﬁlm on abiotic
surfaces, attached less efﬁciently, and formed less cell aggregates on human
intestinal cells. Furthermore, a genome-wide transcriptomic analysis indicated that
c-di-AMP regulates many other important biological processes and modulates the
expression of a few genes associated with pathogenicity. Overall, our results
indicate that c-di-AMP could be an important signaling molecule controlling the
ability of S. gallolyticus to colonize the host.
RESULTS
Deletion of GALLO_2236 results in increased intracellular c-di-AMP levels in S.
gallolyticus subsp. gallolyticus UCN34. In Firmicutes, c-di-AMP is commonly synthe-
sized by diadenylate cyclase DacA and hydrolyzed by a speciﬁc phosphodiesterase,
GdpP (21, 29). In many bacterial genomes, dacA often colocalizes with ybbR and glmM,
whereas gdpP often colocalizes and is coexpressed with rplI and dnaC (18, 32). By
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protein homology search and gene location identiﬁcation in the genome of S. gallo-
lyticus subsp. gallolyticus UCN34, we identiﬁed GALLO_1455 (GenBank accession num-
ber CBI13946) and GALLO_2236 (GenBank accession number CBI14727) as the best
candidates for dacA and gdpP, respectively (33). Further analysis of GALLO_1455 and
GALLO_2236 in the SMART database (http://smart.embl-heidelberg.de) conﬁrmed that
GALLO_1455 and GALLO_2236 contain the typical domain architecture of DacA and
GdpP, respectively (18, 34). In particular, GALLO_1455 contains three transmembrane
regions and a DisA_N domain, whereas GALLO_2236 contains two transmembrane
regions, a PAS sensory domain, a GGDEF domain, and a DHH/DHHA1 catalytic domain
(Fig. 1A and B). We, therefore, renamed GALLO_1455 and GALLO_2236 as dacA and
gdpP, respectively.
Notably, the S. gallolyticus subsp. gallolyticus UCN34 genome neither encodes a
PgpH-type (19) nor a CdnP-type (14) c-di-AMP phosphodiesterase, but it does encode
a stand-alone DHH/DHHA1 domain-containing protein (GALLO_0742). The stand-alone
DHH/DHHA1 domain-containing protein, usually designated as Pde2 (or DhhP), was
previously reported to hydrolyze c-di-AMP (35, 36) but has been shown recently to
preferentially act on linear nucleotides, such as pApA and pGpG (36–38). In addition,
Pde2 also exhibits additional enzymatic properties, such as being a nanoRNA RNase and
a 3’-phosphoadenosine 5’-phosphate (pAp) phosphatase (36, 39, 40). Therefore, to
investigate the roles of c-di-AMP in S. gallolyticus subsp. gallolyticus, the function of
GALLO_0742 was not further explored in this study.
Our multiple attempts to create a dacA deletion mutant in S. gallolyticus subsp.
gallolyticus UCN34 under standard laboratory culturing conditions by employing con-
ventional knockout protocols were unsuccessful, suggesting that c-di-AMP may be
essential for the survival of S. gallolyticus subsp. gallolyticus under standard culturing
conditions, as has been shown for other Gram-positive bacteria (13, 24). Therefore, we
focused on the construction of an in-frame gdpP deletion mutant to modulate the
c-di-AMP levels in S. gallolyticus subsp. gallolyticus UCN34. We deleted the gene
sequence encoding the PAS, the GGDEF, and the DHH/DHHA1 domains of GdpP and
denoted this mutant strain S. gallolyticus subsp. gallolyticus UCN34 ΔgdpP. Of note, 69
bp at the 3= end of gdpP was left undeleted to preserve the ribosomal binding site of
the downstream gene rplI encoding ribosomal subunit L9 (Fig. 1B).
To verify that gdpP truly encodes a c-di-AMP phosphodiesterase in S. gallolyticus subsp.
gallolyticus UCN34, we quantiﬁed the intracellular c-di-AMP levels of S. gallolyticus subsp.
gallolyticus UCN34 wild type, the ΔgdpP mutant, and the gdpP complemented strain
(ΔgdpP/pgdpP). As expected, the intracellular c-di-AMP levels of the ΔgdpP mutant were
approximately 1.5-fold higher than in the wild-type strain UCN34. Importantly, the intra-
cellular c-di-AMP levels in the ΔgdpP/pgdpP complemented strain were about 80% of the
wild-type UCN34 (Fig. 1D), probably due to the overexpression of gdpP in the comple-
mented strain.
S. gallolyticus subsp. gallolyticus UCN34 gdpP is morphologically smaller and
is more sensitive to high osmotic stress than the parental strain. We next investi-
gated the physiological changes in the S. gallolyticus subsp. gallolyticus UCN34 ΔgdpP
mutant in comparison to the wild type and the complemented strain. We ﬁrst moni-
tored the growth kinetics of S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpPmutant,
and the ΔgdpP/pgdpP complemented strain by measuring the optical density of the
bacterial culture inoculated with the same number of cells (approximately 3  107
CFU/ml). Throughout the experimental period, the optical density readings of the
ΔgdpP mutant remained lower than that observed for the wild type and the ΔgdpP/
pgdpP complemented strain (Fig. 2A). However, the doubling times of the three
isogenic strains were similar (28.44 2.16 min, 26.74 2.23 min, and 30.86 1.22 min
for the wild type, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain,
respectively; values are standard deviations [SD]) (see Data Set S1A in the supple-
mental material). A replotted growth curve based on CFU enumeration further showed
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FIG 1 GALLO_1455 and GALLO_2236 encode c-di-AMP diadenylate cyclase and phosphodiesterase, respectively. (A and B) Gene locations
and the domain architecture of GALLO_1455 (A) and GALLO_2236 (B) resemble the typical properties of DacA and GdpP, respectively. PAS,
GGDEF, and DHH/DHHA1 domains were deleted to generate S. gallolyticus subsp. gallolyticus UCN34 ΔgdpP. Sixty-nine base pairs of the
gene at the 3= end of gdpP was left undeleted to preserve the ribosomal binding site of rplI. The arrow at the upstream of GALLO_2236
marks the putative transcriptional start site of GALLO_2236 based on in silico algorithm-based promoter prediction. (C) Liquid
chromatograph-mass spectrometry (LC-MS) quantiﬁcation of the intracellular concentration of c-di-AMP in S. gallolyticus subsp. gallolyticus
UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain. Error bars represent the standard deviation of the measurements
from three samples. Ordinary one-way analysis of variance (ANOVA test): **, P  0.01; ***, P  0.001; ****, P  0.0001.
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that the increased intracellular c-di-AMP levels do not affect the growth of S. gallolyticus
subsp. gallolyticus UCN34 (Data Set S1B).
When the bacterial cells were observed under phase-contrast microscopy, the
UCN34 ΔgdpP mutant cells appeared clearly smaller than the wild type and the
ΔgdpP/pgdpP complemented strain (Fig. 2B). A cell area measurement of 300 cells for
each bacterial strain, using ImageJ software, conﬁrmed that the UCN34 ΔgdpP mutant
cells were about 25% smaller than the wild type and the ΔgdpP/pgdpP complemented
FIG 2 Phenotypic changes associated with an increased intracellular c-di-AMP levels resulted from the deletion of
gdpP. (A) Representative anaerobic growth kinetics of S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpP mutant,
and the ΔgdpP/pgdpP complemented strain. Initial inoculum was prepared from log-phase culture adjusted to
approximately 3  107 CFU/ml. Growth, reﬂected in optical density, was measured at 600 nm (OD600) at the
indicated time point. The arrow indicates the sample collection time point for bioﬁlm assay and the RNA-seq
experiment. Error bars represent the standard deviation of the measurements from three samples. (B) Represen-
tative phase-contrast microscopy images on the stationary-phase culture of the S. gallolyticus subsp. gallolyticus
UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain. Images were acquired with Carl Zeiss Axio
Observer.Z1 inverted wide-ﬁeld microscope ﬁtted with 100/1.3-numerical-aperture (NA) objective oil lens. Images
were processed using Imaris version 8.2. Scale bars  3 m. (C) Cell area measurement of 300 imaged cells from
three independent experiments using ImageJ software. Error bars represent the standard deviation of the 300
measurements. Kruskal-Wallis test: ****, P  0.0001; ns, P  0.05. (D) Representative images of 5 l of S. gallolyticus
subsp. gallolyticus log-phase culture adjusted to approximately 3 107 CFU/ml spotted onto BHI agar and BHI agar
supplemented with 0.4 M NaCl. (E) MICs of ampicillin and penicillin G against S. gallolyticus subsp. gallolyticus
UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain. MIC was determined based on the optical
density reading at 600 nm on a Tecan microplate reader, Inﬁnite M200Pro.
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strain (Fig. 2C). These data suggest that the lower optical density reading observed for
the ΔgdpP mutant may primarily be due to the reduced cell size.
Increased intracellular c-di-AMP levels were previously reported to affect the bacterial
tolerance to high osmotic stress and the sensitivity to -lactam antibiotics (29, 41). There-
fore, we tested the tolerance of S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpPmutant,
and the ΔgdpP/pgdpP complemented strain to high osmotic stress by spotting serially
diluted log-phase culture on brain heart infusion (BHI) agar and BHI agar supplemented
with 0.4 M NaCl. As shown in Fig. 2D, the S. gallolyticus subsp. gallolyticus UCN34 ΔgdpP
mutant was more sensitive than the wild type to high osmotic stress. The tolerance to the
osmotic stress was restored when gdpP was expressed in trans. We next tested the
sensitivity of these 3 strains to -lactam antibiotics. Our data did not show any signiﬁcant
differences in the susceptibility of the ΔgdpPmutant to ampicillin or penicillin G compared
with that of the wild type and the complemented strain (Fig. 2E). Taken together, our data
showed that high intracellular c-di-AMP affects bacterial cell size and tolerance to osmotic
stress but not bacterial growth or sensitivity to -lactam antibiotics in S. gallolyticus subsp.
gallolyticus.
Increased intracellular c-di-AMP levels reduce S. gallolyticus subsp. gallolyticus
bioﬁlm formation. c-di-AMP was previously shown to regulate bioﬁlm formation in a
number of Gram-positive bacteria (29–31, 42). To test the impact of increased intra-
cellular c-di-AMP levels on S. gallolyticus subsp. gallolyticus bioﬁlm formation, conven-
tional bioﬁlm assays on microtiter plates were carried out with S. gallolyticus subsp.
gallolyticus UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain.
Unexpectedly, we found that the bioﬁlm formed by the ΔgdpP mutant was only 57%
of the wild-type level, whereas the bioﬁlm formed by the ΔgdpP/pgdpP complemented
strain was 160% of the wild-type level (Fig. 3A). Confocal laser scanning microscopy
images of the bioﬁlms suggested that the reduced bioﬁlm formation of the ΔgdpP
mutant was primarily due to the reduced attachment of the ΔgdpP mutant cells to the
surfaces (Fig. 3B). Taken together, our data indicate that bioﬁlm formation of S.
gallolyticus subsp. gallolyticus is negatively regulated by c-di-AMP, i.e., an increased
intracellular c-di-AMP level reduces bioﬁlm formation, whereas a decreased intracellular
c-di-AMP level enhances bioﬁlm formation.
Increased intracellular c-di-AMP levels attenuate the ability of S. gallolyticus
subsp. gallolyticus to adhere and to form cell aggregates on human colonic
epithelial cells. We next tested whether c-di-AMP can alter the ability of S. gallolyticus
subsp. gallolyticus to adhere to biotic surfaces, such as human colonic cells. We
introduced S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpP mutant, and the ΔgdpP/
pgdpP complemented strain onto a monolayer of human colorectal adenocarcinoma
HT-29 cells and quantiﬁed the number of adherent bacterial cells after 1 hour of
incubation at 37°C. As for bioﬁlm formation, the ΔgdpP mutant adhered less efﬁciently
on the monolayer of HT-29 cells than the wild type, whereas the complemented
ΔgdpP/pgdpP strain adhered more efﬁciently than the wild type (Fig. 4A). Immunoﬂu-
orescence microscopy showed that S. gallolyticus subsp. gallolyticus UCN34 formed cell
aggregates on HT-29 cells, which was rarely observed for the ΔgdpP mutant. Interest-
ingly, the complemented ΔgdpP/pgdpP strain formed larger cell aggregates than the
wild type on HT-29 cells (Fig. 4B). These data demonstrated that c-di-AMP modulates
the adherence of S. gallolyticus subsp. gallolyticus on both abiotic and biotic surfaces.
c-di-AMP regulates various biological functions in S. gallolyticus subsp. gallo-
lyticus UCN34, including gallocin production and Pil3 pilus biosynthesis. To un-
cover other regulatory roles of c-di-AMP in S. gallolyticus subsp. gallolyticus, genome-
wide transcriptomic sequencing (RNA-seq) was performed on the stationary phase
culture of S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpP mutant, and the ΔgdpP/
pgdpP complemented strain. Comparative transcriptomic analysis revealed 109 genes
whose expression was either upregulated or downregulated by 2-fold in the ΔgdpP
mutant compared with the wild type and the complemented strain. Functional classi-
ﬁcation of these differentially regulated genes suggests that c-di-AMP regulates various
biological functions, such as carbohydrate, amino acid, nucleotide, and coenzyme
Teh et al. Journal of Bacteriology
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transport and metabolism; development of competence for genetic transformation;
DNA replication, recombination, and repair; and translation, ribosomal structure, and
biogenesis, in S. gallolyticus subsp. gallolyticus. In addition, several families of transcrip-
tional regulators were found to be differentially expressed, which may serve as the
mediators for c-di-AMP to regulate the cognate cellular functions (see Data Set S2 in the
supplemental material).
Interestingly, the RNA-seq data also reﬂected that an increased intracellular c-di-
AMP level was associated with the reduced expression of multiple ABC transporters,
including spermidine/putrescine and proline/glycine betaine ABC transporters, which
can be linked to osmotic regulation (Data Set S2). The S. gallolyticus subsp. gallolyticus
UCN34 proline/glycine betaine ABC transporters are the homologs of the B. subtilis
OpuCABCD osmoprotectant ABC transporters. In Staphylococcus aureus and L. mono-
cytogenes, OpuCA containing a cystathionine-synthase (CBS) domain is a known c-di-
AMP-binding protein (27, 43, 44). Whereas a putative homolog of OpuCA can be
identiﬁed in S. gallolyticus subsp. gallolyticus UCN34 (GALLO_1283), GALLO_1283 ap-
pears to be a truncated OpuCA containing no CBS domain, which is similar to the
OpuCA of Streptococcus pneumoniae (45). The CBS domain is required for c-di-AMP
binding (43). Therefore, it is expected that c-di-AMP will not bind to the S. gallolyticus
subsp. gallolyticus OpuCA to regulate the osmoprotectant transporter activity. Instead,
as suggested by the RNA-seq data, c-di-AMP may control the uptake of osmoprotectant
by regulating the transcription of the OpuCA transporter.
Intrigued by this observation, we further explored whether the putative homologs
of other c-di-AMP-binding proteins were also differentially expressed in S. gallolyticus
FIG 3 Accumulation of intracellular c-di-AMP levels inhibits S. gallolyticus subsp. gallolyticus bioﬁlm
formation. (A) Bioﬁlm quantiﬁcation using conventional microtiter plate bioﬁlm assay. Error bars
represent the standard deviation from 12 samples from 3 independent experiments. Ordinary one-way
ANOVA test: ****, P  0.0001. (B) Representative bioﬁlm images of S. gallolyticus subsp. gallolyticus
UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain acquired using Carl Zeiss
confocal laser scanning microscope LSM780 ﬁtted with Plan Apochromat 100/1.4-NA oil objective
lens, with excitation at 488 nm. Scale bars  10 m.
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subsp. gallolyticus UCN34 ΔgdpP. These homologs include GALLO_2236 (homolog of
PdeA) (46), GALLO_1832 (homolog of K transporter KtrA/KtrC/CabP/CabPA) (27, 31,
47–49), GALLO_1797 (homolog of K transporter CabPB) (27, 31), GALLO_1748 (ho-
molog of PII-like signal transduction protein PstA) (46, 47, 50, 51), GALLO_1804 (ho-
molog of hypothetical protein CbpB) (46), GALLO_1824 (homolog of transcriptional
repressor NrdR) (46), and GALLO_2191 (homolog of recombination protein A RecA) (52).
Notably, homologs of many other known c-di-AMP-binding proteins, such as cation/
proton antiporter CpaA (46, 47, 53), sensor kinase KpdD (47, 54), transcriptional
regulator BusR (27, 55) and DarR (56), pyruvate carboxylase PycA (46), hypothetical
protein CbpA (46), and Lmo1466 (46), were not found in S. gallolyticus subsp. gallolyti-
cus UCN34 (Table 1). None of these homologs, except the knocked out protein
PdeA/GdpP, were differentially expressed in the S. gallolyticus subsp. gallolyticus ΔgdpP
FIG 4 Increased intracellular c-di-AMP levels attenuate the ability of S. gallolyticus subsp. gallolyticus to adhere and
to form cell aggregates on human colonic epithelial cells. (A) Quantiﬁcation of the cell number of S. gallolyticus
subsp. gallolyticus attached on a monolayer HT-29 human colorectal adenocarcinoma cells. Error bars represent the
standard deviation of 9 samples from 3 independent experiments. Kruskal-Wallis test: **, P  0.01; ***, P  0.001;
ns, P  0.05. (B) Representative immunoﬂuorescence images of the S. gallolyticus subsp. gallolyticus adhered on a
monolayer of HT-29 human colorectal adenocarcinoma cells. Green, S. gallolyticus subsp. gallolyticus labeled with
primary antibody rabbit UCN34 and secondary goat anti-rabbit antibody conjugated with Alexa Fluor 488. Blue,
Hoechst 33342-stained DNA of the HT-29 cells. Scale bars  10 m (top) and 70 m (bottom).
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mutant compared with the wild type UCN34 and the complemented strain (Data Set
S2). This result was not unexpected given that c-di-AMP interacts with the binding
proteins to directly modulate the protein activity.
Importantly, the transcription of the blpB encoding gallocin and the blpC encoding
gallocin immunity protein (10) was upregulated (2 fold), whereas the expression of pil3A,
pil3B, and srtC of the Pil3 operon (12) was downregulated (4 fold) in the ΔgdpP mutant
compared with the wild type and the complemented strain (Data Set S2). Gallocin and Pil3
pilus were previously shown as two important colonization factors enabling S. gallolyticus
subsp. gallolyticus to persist in the murine colon (10, 12). The RNA-seq data indicating that
these colonization factors are differentially expressed in the ΔgdpPmutant prompted us to
assess the gallocin production and Pil3 pilus biosynthesis in the three isogenic S. gallolyticus
subsp. gallolyticus strains. To measure gallocin production, we spotted approximately 2 
105 log-phase cells of UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented
strain onto BHI agar ﬂooded with the gallocin-sensitive strain Enterococcus faecalis OG1RF
and S. gallolyticus subsp.macedonicus (10). The S. gallolyticus subsp. gallolyticus UCN34 Δblp
mutant producing no gallocin was used as a negative control (10). After an overnight
incubation under anaerobic conditions, the S. gallolyticus subsp. gallolyticus UCN34 ΔgdpP
mutant created a larger zone of inhibition than the wild type and the ΔgdpP/pgdpP
complemented strain, demonstrating an increased gallocin production in the ΔgdpP mu-
tant (Fig. 5B). To quantify Pil3 biosynthesis, Western blot analysis was carried out using the
cell wall proteins from UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented
strain. We included the isogenic UCN34 Δpil3 to check for antibody speciﬁcity. Our data
showed that Pil3 expression was noticeably decreased in the ΔgdpPmutant compared with
the wild type and the ΔgdpP/pgdpP complemented strain (Fig. 5C). Taken together, these
data indicate that c-di-AMP modulates gallocin and Pil3 levels in S. gallolyticus subsp.
gallolyticus.
DISCUSSION
Streptococcus gallolyticus subsp. gallolyticus is an emerging pathogen responsible
for septicemia and endocarditis in the elderly, whose presence is strongly associ-
ated with the occurrence of colorectal cancer (7, 8, 57–60). Here, we investigated
the roles of c-di-AMP in this emerging pathogen. We show that c-di-AMP plays a
pleiotropic role in S. gallolyticus subsp. gallolyticus, controlling the tolerance to
osmotic stress, cell size, bioﬁlm formation, adherence to intestinal cells, cell aggre-
gate formation, gallocin production, and Pil3 pilus expression.
TABLE 1 Protein homologs of the known c-di-AMP-binding proteins in S. gallolyticus
subsp. gallolyticus UCN34
Known c-di-AMP-binding protein
Homolog in
UCN34
Differentially regulated by
>2-fold in S. gallolyticus
subsp. gallolyticus gdpP?
Osmoprotectant transport ATP-binding
protein OpuCA
GALLO_1283a Yes
DHH subfamily 1 protein PdeA GALLO_2236 Yes
K transporter KtrA/KtrC/CabP/CabPA GALLO_1832 No
K transporter CabPB GALLO_1797 No
PII-like signal transduction protein PstA GALLO_1748 No
Hypothetical protein CbpB GALLO_1804 No
Transcriptional repressor NrdR GALLO_1824 No
Recombination protein A RecA GALLO_2191b No
Cation/proton antiporter CpaA Not found Not applicable
Sensor kinase KdpD Not found Not applicable
Transcriptional regulator BusR Not found Not applicable
Hypothetical protein Lmo1466 Not found Not applicable
Pyruvate carboxylase PycA Not found Not applicable
Hypothetical protein CbpA Not found Not applicable
Transcriptional regulator DarR Not found Not applicable
aHomolog of OpuCA containing no cystathionine-synthase (CBS) domain.
bDoes not contain the conserved motif of MsRecA for the binding of c-di-AMP.
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c-di-AMP has been proposed to regulate several processes in Gram-positive bacteria.
One of the conserved roles is to maintain osmotic homeostasis (41). We speculate that
c-di-AMP maintains this conserved role in S. gallolyticus subsp. gallolyticus for two
reasons. First, the observations that the S. gallolyticus subsp. gallolyticus ΔgdpP mutant
is more sensitive to osmotic stress and exhibits altered bacterial morphology suggest
an underlying perturbation in the cellular turgor to osmotic pressure (28, 41, 61).
Second, our RNA-seq data suggest that at high intracellular c-di-AMP levels, the
expression of spermidine/putrescine and proline/betaine glycine ABC transporters was
downregulated in S. gallolyticus subsp. gallolyticus. These transporters are crucial for
bacterial cells for rapid osmotic adjustment during osmotic shift (62, 63). Combined,
FIG 5 c-di-AMP regulates the gallocin production and Pil3 biosynthesis in S. gallolyticus subsp. gallolyti-
cus. (A) Gallocin production by S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpP mutant, and the
ΔgdpP/pgdpP complemented strain under anaerobic conditions. Five microliters of S. gallolyticus subsp.
gallolyticus UCN34, the ΔgdpP mutant, and the ΔgdpP/pgdpP complemented strain log-phase culture
adjusted to approximately 3  107 CFU/ml was spotted onto BHI agar ﬂooded with Enterococcus faecalis
OG1RF or S. gallolyticus subsp.macedonicus. Zone of clearance reﬂects the growth inhibition of E. faecalis
or S. gallolyticus subsp.macedonicus. The strain deﬁcient in producing the gallocin Δblpmutant was used
as the negative control. (B) Western blot analysis of the cell wall proteins from S. gallolyticus subsp.
gallolyticus UCN34, the ΔgdpPmutant, and the ΔgdpP/pgdpP complemented strain. Equal amounts of the
cell wall proteins were loaded (right) and probed with speciﬁc polyclonal antibodies against Pil3B (left).
Cell wall proteins of the S. gallolyticus subsp. gallolyticus UCN34 Δpil3 mutant was used as a negative
control. Theoretical positions of Pil3B monomers, based on the molecular weights, are indicated (m), and
high-molecular-weight species corresponding to pilus polymers are labeled (p).
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these data point toward a role of c-di-AMP in maintaining osmotic homeostasis in S.
gallolyticus subsp. gallolyticus. Another proposed role of c-di-AMP is to indirectly
mediate sensitivity to -lactam antibiotics (41). However, we did not observe a signif-
icant difference in the MIC of -lactam antibiotics across our wild type, the ΔgdpP
mutant, and the ΔgdpP/pgdpP complemented strain. Similar observations were also
reported in Streptococcus suis (30), suggesting that c-di-AMP may not mediate the
sensitivity to -lactam antibiotics in Streptococcus spp.
Notably, an increased intracellular c-di-AMP level reduces bioﬁlm formation in S.
gallolyticus subsp. gallolyticus. A similar ﬁnding was reported in B. subtilis (42). This
result is in contrast to several other publications showing the opposite effect of
c-di-AMP on the bioﬁlm formation of S. aureus, S. suis, and Streptococcus mutans
(29–31). The detailed mechanisms explaining how c-di-AMP affects the bioﬁlm forma-
tion in S. gallolyticus subsp. gallolyticus are currently being investigated. It is important
to emphasize that both S. gallolyticus subsp. gallolyticus and bacterial bioﬁlms can play
a role in the development of colorectal cancer (9, 64–67). It would be interesting to
explore whether the presence of S. gallolyticus subsp. gallolyticus bioﬁlms plays a role
as the potential promoting factor in the development of colorectal cancer, and this can
be approached by manipulating the intracellular c-di-AMP levels to modulate the
bioﬁlm formation of S. gallolyticus subsp. gallolyticus.
It is also worth mentioning that although the Pil3 pilus is an important colonization
factor for S. gallolyticus in vivo in the murine colon, it plays a minor role in mediating
the adherence of S. gallolyticus on HT-29 cells in vitro (12). Therefore, the reduced
expression of Pil3 pilus in the S. gallolyticus subsp. gallolyticus ΔgdpP mutant may not
solely account for the reduced adherence of the S. gallolyticus subsp. gallolyticus ΔgdpP
mutant on HT-29 cells. We speculate that in the ΔgdpP mutant, the combined effects
of the reduced expression of Pil3 pilus and of other putative adhesins may instead
account for the reduced adherence on HT-29 cells and the absence of cell aggregates.
Given that cell aggregates may progressively develop into bioﬁlms (68), it awaits further
investigation on whether Pil3 pilus and the putative adhesins establish a link between
bioﬁlm formation, cell attachment, cell aggregation, and potentially host colonization
in S. gallolyticus subsp. gallolyticus.
In this study, despite a relatively low difference in the intracellular c-di-AMP levels in
the S. gallolyticus subsp. gallolyticus ΔgdpP mutant and the ΔgdpP/pgdpP comple-
mented strain compared with the wild type, signiﬁcant phenotypic differences were
observed especially in terms of bioﬁlm formation and adherence on intestinal cells.
Small differences in the intracellular c-di-AMP were also observed for S. pneumoniae, S.
suis, and B. subtilis and their isogenic gdpP mutants (16, 30). In sharp contrast, S. aureus
and S. agalactiae gdpP mutants were shown to accumulate up to 38-fold more
intracellular c-di-AMP than the parental strains (27, 29). The driving factors for the
difference are currently unclear.
In conclusion, we report here that the second messenger signaling molecule
c-di-AMP controls osmotic tolerance, bioﬁlm formation on abiotic surfaces, adherence
on human intestinal cells, formation of cell aggregates, expression of pilus proteins, and
production of bacteriocin in S. gallolyticus subsp. gallolyticus. This study, thus, indicates
that c-di-AMP could be an important signaling molecule governing the pathogenicity
of S. gallolyticus subsp. gallolyticus.
MATERIALS AND METHODS
Bacterial strains, culturing conditions, plasmids, and primers. All bacterial strains, plasmids, and
primers used in this study are listed in Table 2. Unless stated otherwise, an overnight culture of S.
gallolyticus subsp. gallolyticus UCN34 was typically prepared from a single colony in 5 ml of M9YEG broth
(1 M9 minimal salts [MP Biomedicals] supplemented with 0.5% of yeast extract [Becton, Dickinson, and
Company] and 1.0% glucose [VWR]) and incubated at 37°C under static conditions for 12 to 14 hours. The
overnight culture was diluted (1:5) in M9YEG broth the next day and incubated further at 37°C for the
preparation of log-phase culture. When necessary, erythromycin was supplemented to a ﬁnal concen-
tration of 2 g/ml (Sigma-Aldrich).
Construction of gdpP deletion mutant. The construction of the gdpP in-frame deletion mutant was
performed as previously described (69, 70). In brief, two approximately 1-kb DNA fragments correspond-
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ing to the 5= and 3= end of gdpP were PCR-ampliﬁed using primer pairs gdpP_up_F/gdpP_up_R and
gdpP_dn_F/gdpP_dn_R. The resulting PCR products were puriﬁed and further ampliﬁed using primer
pair gdpP_up_F and gdpP_dn_R and subsequently cloned into pG1 plasmid, generating pG1::gdpPKO.
pG1::gdpPKO was introduced into S. agalactiae NEM316 (71) by electroporation and later into S.
gallolyticus subsp. gallolyticus UCN34 by conjugal transfer. S. gallolyticus subsp. gallolyticus UCN34 with
pG1::gdpPKO integrated into the genome was selected by growing the bacteria at 37°C in the presence
of erythromycin. Next, integrants were serially passaged at 30°C in BHI broth without antibiotic to
facilitate the excision of the plasmid by homologous recombination. An in-frame deletion of gdpP gene
was veriﬁed by PCR and Sanger sequencing of the gdpP-chromosomal ﬂanking regions.
Construction of gdpP complemented strain. A DNA fragment containing the putative promoter
and the full-length open reading frame of GALLO_2236 was ampliﬁed by PCR using the primer pair
gdpP_F and gdpP_R. The PCR product was restricted with BamHI and SphI and ligated to BamHI/SphI-
restricted pTCVerm-oriTTnGBS1, generating a GALLO_2236 complementation plasmid, pTCVerm::gdpP. The
complementation plasmid was introduced into Escherichia coli DH5 and then extracted and sequenced.
Next, it was introduced into S. agalactiae NEM316 and later into S. gallolyticus subsp. gallolyticus UCN34
ΔgdpP, as described earlier (70).
Preparation of c-di-AMP extract. Intracellular c-di-AMP was extracted following the published
protocol, with minor modiﬁcations (29). A total of 6 ml of log-phase culture adjusted to approximately
3  107 CFU/ml was added into each well of a 6-well plate. After 5 hours of incubation at 37°C under
anaerobic conditions (0% O2, 10% CO2; AnaeroGen Compact, prepared according to the manufacturer’s
instruction; Thermo Fisher Scientiﬁc), the bacterial culture was well mixed by using cell scrapers (TPP) and
repeated pipetting. A total of 300 l of the well-mixed bacterial culture was collected, pelleted, lysed in
300 l of 0.1 M NaOH for 10 minutes at 80°C, and was subjected to protein quantiﬁcation with a Qubit
2.0 ﬂuorometer (Thermo Fisher Scientiﬁc) for normalization purposes. Five milliliters of the well-mixed
bacterial culture was transferred to a 15-ml Falcon tube and centrifuged at 8,000  g for 2 minutes at
4°C. The bacterial pellet was washed once with 0.9% NaCl. One milliliter of ice-cold extraction buffer (40%
[vol/vol] acetonitrile, 40% [vol/vol] methanol, and 20% ultrapure water) was added to the pellet, and the
suspension was mixed well. The samples were snap-frozen in liquid nitrogen for 30 seconds before being
boiled for 10 minutes. The samples were subsequently transferred to Lysing Matrix B tubes (MP
Biomedicals) and were homogenized in a FastPrep-24 instrument at a setting of 6.0 m/s for 45 seconds
(MP Biomedicals) before being separated from the silica beads by centrifugation at 17,000  g for 5
minutes at 4°C. A total of 600 l of the top layer was transferred to a new tube. The silica beads/cell
debris mixture was added with 1 ml of ice-cold extraction buffer, brieﬂy vortexed, and incubated on ice
for 5 minutes, before a second centrifugation at the same setting. The top layer was again collected and
combined with the ﬁrst extract. The samples were dried at 4°C in a CentriVap centrifugal vacuum
concentrators (Labconco). Dried samples were stored at 80°C until analysis.
Quantiﬁcation of c-di-AMP extract by liquid chromatography-mass spectrometry analysis.
Detection and quantiﬁcation of c-di-AMP were performed as described previously with modiﬁcations (72)
at the Singapore Phenome Centre. Brieﬂy, it was performed with a Xevo TQ-S instrument (Waters) with
TABLE 2 Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or primer Description Reference or source
Strains
E. coli DH5 deoR endA1 gyrA96 hsdR17 (Δlac)U169 recA1 relA1 supE44 thi-1 (80 lacZΔM15) Lab collection
S. gallolyticus subsp.
gallolyticus UCN34
A clinical strain isolated from an infective endocarditis patient who later diagnosed
with CRCa
33
UCN34 ΔgdpP In-frame gdpP (GALLO_2236) knockout mutant This study
UCN34 ΔgdpP/pgdpP gdpP complemented strain; UCN34 ΔgdpP containing pTCVerm::gdpP This study
UCN34 Δpil3 In-frame pil3 (GALLO_2038 to GALLO_2042) knockout mutant 12
UCN34 Δblp Gallocin-deﬁcient knockout mutant (GALLO_2021 to GALLO_2020) 10
S. agalactiae NEM316 MLST-23, serotype III isolated from neonate blood culture 73
E. faecalis OG1RF Derived from a clinical isolate OG1; rifampicin and fusidic acid resistant From Kimberly Kline
Plasmids
pG1 Em; oriR pUC; oriR(Ts) pWV01; MCS pUC18 72
pG1::gdpPKO pG1 containing 2-kb fragment corresponding to the 5= and 3= end of GALLO_2236 This study
pTCVerm-oriTTnGBS1 Em Km Mob (IncP); oriR pACYC184; oriR pAM1; MCS lacZ 72
pTCVerm::gdpP pTCVerm-oriTTnGBS1 containing promoter and ORF of gdpP (GALLO_2236) This study
Primers
gdpP_up_F GTCAAACCAATGGTACG This study
gdpP_up_R TAAGTGTTCGGCTTGACTCAAGCCTATCATGACTAA This study
gdpP_dn_F TTAGTCATGATAGGCTTGAGTCAAGCCGAACACTTA This study
gdpP_dn_R CTGCGATTGCTATGTTC This study
gdpP_F CACAGGATCCGTTTACCTAGAAGGCAAGb This study
gdpP_R CACAGCATGCCATCACTCTACCTCCATb This study
aCRC, colorectal cancer.
bRestriction sites are underlined.
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a binary pump, a temperature-controlled autosampler maintained at 4°C, and a column oven compart-
ment maintained at 40°C, interfaced to the electrospray ionization (ESI) positive ion source. A total of 5
l of the c-di-AMP extract dissolved in 100 l of water was injected into a BEH C18 column (1.7 m; 2.1
by 50 mm; Waters). Mobile phase A was 10 mM ammonium formate in water containing 0.1% formic acid,
whereas mobile phase B was methanol containing 0.1% formic acid. Samples were run in gradient
condition, with 100% mobile phase A from initial to 3 minutes, 80% mobile phase A from 3 to 3.5
minutes, 10% mobile phase A from 3.5 to 6.5 minutes, and 100% mobile phase A from 6.6 to 8 minutes.
The total run was 8 minutes, with a ﬂow rate of 0.30 ml per minute. Software MassLynx and TargetLynx
were used for chromatography and quantiﬁcation of c-di-AMP, respectively.
Growth curve of S. gallolyticus subsp. gallolyticus UCN34 and derivatives. A log-phase S.
gallolyticus subsp. gallolyticus culture was diluted to approximately 3 107 CFU/ml in M9YEG broth. One
milliliter of the culture was seeded into each well of a 24-well plate and incubated at 37°C under
anaerobic conditions. The bacterial growth was monitored at the desired time point by optical density
(OD) measurement at 600 nm using a UV spectrophotometer.
Antibiotic susceptibility test. Ampicillin and penicillin G (Sigma-Aldrich) dissolved in water were 2
serially diluted in M9YEG broth in a 96-well microtiter plate. One hundred microliters of log-phase S.
gallolyticus subsp. gallolyticus culture diluted to approximately 1  106 CFU/ml was added into the wells
containing antibiotics. After a 20-hour incubation, the plate was measured at a wavelength of 600 nm
on a microplate reader, Inﬁnite M200Pro (Tecan). The lowest concentration of antibiotics that inhibited
the bacterial growth was determined as the MIC.
Microtiter plate bioﬁlm assay. The assay was performed as described with modiﬁcations (73). One
milliliter of log-phase S. gallolyticus subsp. gallolyticus culture diluted to approximately 3  107 CFU/ml
was added into each well of a 24-well plate and incubated at 37°C under anaerobic conditions (0% O2,
10% CO2; AnaeroGen Compact, prepared according to the manufacturer’s instruction; Thermo Fisher
Scientiﬁc). After 5 hours of incubation, the bacterial culture was removed. The wells were washed twice
with 0.9% NaCl, before being stained with 1 ml of 0.1% of crystal violet solution for 15 minutes. Following
this step, the crystal violet solution was removed, the wells were washed twice with 0.9% NaCl, and the
bioﬁlm was solubilized by 30% acetic acid for 15 minutes. Solubilized bioﬁlm was quantiﬁed and
measured on a microplate reader, Inﬁnite M200Pro (Tecan), at a wavelength of 550 nm.
Confocal laser scanning microscopy imaging. The 5-hour bioﬁlms formed by S. gallolyticus subsp.
gallolyticus UCN34 and the derivatives under anaerobic conditions were washed with 0.9% NaCl twice,
ﬁxed with 4% paraformaldehyde for 10 minutes, and stained with SYTO9 (1:500 diluted from stock;
Thermo Fisher Scientiﬁc) for 10 minutes. Bioﬁlm images were acquired using LSM780 inverted confocal
laser scanning microscope (Carl Zeiss) ﬁtted with Plan Apochromat 100/1.4-numerical-aperture (NA) oil
objective lens, with excitation at 488 nm. The images were processed using Imaris version 8.2.0 (Bitplane).
Cell adherence assay. The human colorectal adenocarcinoma cell line ATCC HTB-38 (HT-29) was
routinely maintained in Dulbecco modiﬁed Eagle medium (DMEM) high glucose (with L-glutamine,
without sodium pyruvate; Gibco) supplemented with 10% fetal bovine serum. One milliliter of the
log-phase S. gallolyticus subsp. gallolyticus culture diluted to approximately 5  107 CFU/ml was seeded
onto a monolayer of HT-29 cells cultured in a 24-well plate, with a multiplicity of infection of 20. After
1 hour of incubation at 37°C and 5% CO2, the monolayer was washed two times with phosphate-buffered
saline (PBS) to remove the nonadherent bacteria. The monolayer was resuspended in 0.05% Triton X-100.
The amount of adherent bacteria was determined by CFU count.
Immunoﬂuorescence imaging. A monolayer of HT-29 cells was infected as described above in “Cell
adherence assay.” Following incubation, the monolayer was washed once with PBS and ﬁxed in 4%
paraformaldehyde for 15 minutes. The samples were subsequently incubated for 1 hour in PBS contain-
ing rabbit anti-UC34 (1:200), followed by an additional 1-hour incubation in PBS containing Alexa Fluor
488-conjugated goat anti-rabbit antibody (1:200; Abcam) and Hoechst 33342 (1:500; Thermo Fisher
Scientiﬁc) (10). The samples were imaged using an LSM780 inverted confocal laser scanning microscope
(Carl Zeiss) ﬁtted with Plan Apochromat 40/1.3-NA and 63/1.4-NA oil objective lenses, with excitation
at 405 nm and 488 nm. Tile scan images were stitched using Image Stitching plug-ins on Fiji (74). All
images were processed using Imaris version 8.2.0 (Bitplane).
RNA extraction and sequencing. One milliliter of the log-phase S. gallolyticus subsp. gallolyticus
culture diluted to approximately 3  107 CFU/ml was added into each well of a 24-well plate and
incubated at 37°C under anaerobic conditions (0% O2, 10% CO2; AnaeroGen Compact, prepared
according to the manufacturer’s instruction; Thermo Fisher Scientiﬁc). After 5 hours of incubation, the
bacterial culture was removed and preserved in 2 volumes of RNAprotect bacterial reagent (Qiagen) and
extracted using an RNeasy minikit (Qiagen) according to the manufacturer’s instruction. The extracted
RNA was depleted by using a Ribo-Zero rRNA removal kit (Bacteria) (Illumina) and converted to cDNA by
using the NEBNext RNA ﬁrst strand synthesis module and NEBNext Ultra directional RNA second strand
synthesis module (New England Biolabs) and subsequently sequenced on the Illumina HiSeq 2500
platform (100-bp paired-end reads) in our in-house sequencing facility.
RNA-seq data analysis and functional annotation. The sequencing raw reads from the RNA-seq
experiment were trimmed and mapped to the S. gallolyticus subsp. gallolyticus UCN34 genome with CLC
Genomics Workbench 8.0. A differential analysis of the S. gallolyticus subsp. gallolyticus UCN34, the ΔgdpP
mutant, and the ΔgdpP/pgdpP complemented strain was performed using the R/Bioconductor DEseq2
package. Functional annotation on the differentially regulated genes was performed based on Clusters
of Orthologous Groups (COG) classiﬁcation and manually corrected based on published literatures.
Cell wall extract preparation and immunoblotting. Cell wall extracts were prepared as described
earlier (75) and quantiﬁed using a Qubit 2.0 ﬂuorometer (Thermo Fisher Scientiﬁc). Equal amounts of the
Roles of c-di-AMP in S. gallolyticus subsp. gallolyticus Journal of Bacteriology
March 2019 Volume 201 Issue 6 e00597-18 jb.asm.org 13
 o
n
 July 12, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
cell wall extracts were boiled in NuPAGE lithium dodecyl sulfate (LDS) sample buffer (Thermo Fisher
Scientiﬁc), separated by SDS-PAGE on a NuPAGE 4 to 12% bis-Tris protein gradient gel (Thermo Fisher
Scientiﬁc), and transferred to a polyvinylidene diﬂuoride (PVDF) membrane using an iBlot transfer pack
(Thermo Fisher Scientiﬁc). The membrane was blocked in casein blocking buffer (Sigma-Aldrich) and
incubated for 1 hour with rabbit primary Pil3B antibodies (1:1,000) and subsequently with horseradish
peroxidase-conjugated goat anti-rabbit antibody (1:5,000). The membrane was washed 3 times with PBS
and 0.1% Tween 20 between the incubation with antibodies. Chemiluminescence was detected on a
ChemiDoc gel imaging system (Bio-Rad Laboratories).
Accession number(s). The raw RNA-seq reads were deposited at the NCBI Sequence Read Archive
(SRA) database under BioProject number PRJNA484077.
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